Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Good point. It is a tremendous undertaking to manufacture ,distribute, market and sell a new drug flawlessly.

It is hard to imagine IPIX making the right personnel and business structural changes quickly enough to satisfy the demand of a new successful Covid drug. The key would be to find the pharmaceutical company to enter into a partnership or licensing agreement.

An example of a Covid pharmaceutical start up small partnering with a big Pharma for the reasons outlined above would be the Pfizer Bionet deal:

" Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and Europe, and scale-up manufacturing capacity to support global supply
Potential to supply millions of vaccine doses by the end of 2020 subject to technical success of the development program and approval by regulatory authorities, and then rapidly scale up capacity to produce hundreds of millions of doses in 2021.
BioNTech will contribute multiple mRNA vaccine candidates as part of its BNT162 COVID-19 vaccine program, which are expected to enter human testing in April 2020
Pfizer will contribute its leading global vaccine clinical research and development, regulatory, manufacturing and distribution infrastructure and capabilities
BioNTech will receive an upfront payment of $185 million, including an equity investment of approximately $113 million, and be eligible to receive future milestone payments of up to $563 million for a potential total consideration of $748 million."

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-further-details-collaboration

If Brilacidin proves to be successful in the clinical trials the terms above are likely too conservative. Brilaciidin would be in a stage 3 trial with an EUA after the interim report at the earliest.

Good luck to all,

Farrell